Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3.18% is 39% below its 4-year average of -2.29%, near the high end of its 4-year range (-86.43%–8.37%).
75.77% above its 12-month average of -13.12%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1.95%.
NET PROFIT MARGIN
-3.18%
NET PROFIT MARGIN AVG TTM
-13.12%
NET PROFIT MARGIN AVG 3Y
-5.84%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+75.77%
CURRENT VS 3Y AVG
+45.57%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.50%
median of 100 covered companies
CURRENT VS SECTOR MEDIAN
-137.39%
vs the sector median at left
Fortrea Holdings Inc.
Market Cap
$1.90B
Net Profit Margin
-3.18%
TTM Avg
-13.12%
3Y Avg
-5.84%
5Y Avg
N/A
Market Cap
$1.74B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.71B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$2.16B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.52B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.76B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$1.00B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$474.59M
Net Profit Margin
-6.77%
TTM Avg
-13.38%
3Y Avg
-17.48%
5Y Avg
-11.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | $1.90B | -3.18% | -13.12% | -5.84% | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -14.99% | -20.12% | -16.95% | -10.04% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -672.16% | -753.31% | -935.73% | -797.48% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -54.75% | -325.19% | -290.00% | -135445.82% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 22.69% | 19.73% | -2.42% | -44.65% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -7.13% | -23.45% | -155.72% | -114.72% |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -6.77% | -13.38% | -17.48% | -11.79% |
| NRC Health (NRC)vs › | $458.62M | 4.18% | 12.88% | 16.89% | 20.14% |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | -58.33% | -67.34% | -66.78% | -66.78% |
Operating Margin
0.4%
Net Profit Margin
-3.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1.95% |
| 2026-03-31 | -3.71% |
| 2025-12-31 | -4.92% |
| 2025-09-30 | -2.27% |
| 2025-06-30 | -52.78% |
| 2025-03-31 | -86.43% |
| 2024-12-31 | -8.78% |
| 2024-09-30 | -4.13% |
| 2024-06-30 | -20.89% |
| 2024-03-31 | -15.25% |
| 2023-12-31 | -4.64% |
| 2023-09-30 | -1.96% |
| 2023-06-30 | 4.25% |
| 2023-03-31 | 1.80% |
| 2022-12-31 | 5.31% |
| 2022-09-30 | 7.95% |
| 2022-06-30 | 8.37% |
| 2022-03-31 | 4.17% |
